Treatment Patterns and Outcomes of Patients with Acute Myeloid Leukemia (AML) from 2013 to 2022: A Connect ® Myeloid Registry Study

Authors

David L. Grinblatt
Gail J. Roboz
Daniel A. Pollyea
Mikkael A. Sekeres
Bart L. Scott
Karen Seiter, New York Medical CollegeFollow
Amer M. Zeidan
Jay L. Patel
Guillermo Garcia-Manero
Rami S. Komrokji
Michael R. Savona
Irene S. Degutis
Pavel Kiselev
Edward Yu
Willem Heydendael
Ying Qiu
Sara Vergara
Ali McBride
Harry P. Erba

Author Type(s)

Faculty

DOI

10.1182/blood-2023-189963

Journal Title

Blood

First Page

593

Document Type

Article

Publication Date

11-2-2023

Department

Medicine

Disciplines

Medicine and Health Sciences

Recommended Citation

Grinblatt, D. L., Roboz, G. J., Pollyea, D. A., Sekeres, M. A., Scott, B. L., Seiter, K., Zeidan, A. M., Patel, J. L., Garcia-Manero, G., Komrokji, R. S., Savona, M. R., Degutis, I. S., Kiselev, P., Yu, E., Heydendael, W., Qiu, Y., Vergara, S., McBride, A., & Erba, H. P. (2023). Treatment Patterns and Outcomes of Patients with Acute Myeloid Leukemia (AML) from 2013 to 2022: A Connect ® Myeloid Registry Study. Blood, 142 (Suppl. 1), 593. https://doi.org/10.1182/blood-2023-189963